General discussion, page-7126

In a nutshell, the company has been all about developing treatments for unmet needs where the TAM is $1B+ - most of these drugs have so far shown outstanding results in preclinical trials

Have a look at the latest company preso or even better, Canary Capital has put together a brilliant web page that encapsulates everything this company is about

https://canarycapital.com.au/incannex-2/

There is also this schematic put together by one our astute posters here @thevinnys which at a glance shows you how far advanced this company is in a relatively short space of time and the enormous potential here


And of course the SP should continue to run hard now that the BOD has announced the company will soon be listed on the NASDAQ under ticker IXHL - very exciting times ahead